Taysha Gene Therapies, Inc. Rings the Closing Bell in Celebration of its IPO

ABOUT THIS EVENT

Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric gene therapy company with a mission to eradicate monogenic CNS disease, rings the Nasdaq Closing Bell remotely from across the country.

In celebration of its IPO, RA Session, CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.